Skip to main content

Advertisement

Log in

Pain pharmacology in migraine: focus on CGRP and CGRP receptors

  • PHARMACOLOGY AND PATHOPHYSIOLOGY OF NEUROMODULATION
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Over the last 100 years, the discovery of new analgesics has been a complex and difficult task. However, remarkable progress in the identification of novel molecular targets relevant for pain medicines has been reported. Here we will focus on the neuropeptide calcitonin generelated peptide (CGRP) and its receptors (CGRP-R) because of their role in migraine mechanism and migraine therapy. Recent preclinical and clinical data on the localisation, regulation and plasma levels of CGRP and on the function of CGRP-R will be summarised. The reviewed findings highlight the major function of CGRP in migraine and the use of CGRP-R antagonists as a novel approach for the treatment of migraine attack and, perhaps, as migraine prophylactic medicines.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. Geppetti.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Benemei, S., Nicoletti, P., Capone, J.A. et al. Pain pharmacology in migraine: focus on CGRP and CGRP receptors. Neurol Sci 28 (Suppl 2), S89–S93 (2007). https://doi.org/10.1007/s10072-007-0757-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-007-0757-5

Key words

Navigation